sulforaphane has been researched along with Disease Exacerbation in 10 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have shown previously that naturally occurring isothiocyanates derived from cruciferous vegetables and their N-acetylcysteine conjugates inhibit lung adenoma formation induced by tobacco carcinogens in A/J mice at the post-initiation stage." | 7.73 | Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. ( Chung, FL; Conaway, CC; Hecht, SS; McIntee, EJ; Pittman, B; Schwartz, JE; Tian, D; Wang, CX; Yang, YM, 2005) |
| "We have shown previously that naturally occurring isothiocyanates derived from cruciferous vegetables and their N-acetylcysteine conjugates inhibit lung adenoma formation induced by tobacco carcinogens in A/J mice at the post-initiation stage." | 3.73 | Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. ( Chung, FL; Conaway, CC; Hecht, SS; McIntee, EJ; Pittman, B; Schwartz, JE; Tian, D; Wang, CX; Yang, YM, 2005) |
| "Pancreatic cancer is a deadly disease killing 37,000 Americans each year." | 1.39 | A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions. ( Grandhi, BK; Prabhu, S; Thakkar, A; Wang, J, 2013) |
| "However, the disease progression remains unaffected, because of continuous dopaminergic neuron loss." | 1.37 | Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism. ( Cuadrado, A; Fernández-Ruiz, J; Hesse, M; Innamorato, NG; Jazwa, A; Rojo, AI, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, S | 1 |
| Wang, Z | 1 |
| Liu, J | 1 |
| Wang, HD | 1 |
| Yuan, Q | 1 |
| Koolivand, M | 1 |
| Ansari, M | 1 |
| Piroozian, F | 1 |
| Moein, S | 1 |
| MalekZadeh, K | 1 |
| Yin, L | 1 |
| Xiao, X | 2 |
| Georgikou, C | 1 |
| Yin, Y | 2 |
| Liu, L | 2 |
| Karakhanova, S | 1 |
| Luo, Y | 1 |
| Gladkich, J | 2 |
| Fellenberg, J | 1 |
| Sticht, C | 1 |
| Gretz, N | 1 |
| Gross, W | 2 |
| Herr, I | 2 |
| Yoo, IH | 1 |
| Kim, MJ | 1 |
| Kim, J | 1 |
| Sung, JJ | 1 |
| Park, ST | 1 |
| Ahn, SW | 1 |
| Grandhi, BK | 1 |
| Thakkar, A | 1 |
| Wang, J | 1 |
| Prabhu, S | 1 |
| Traka, MH | 1 |
| Melchini, A | 1 |
| Mithen, RF | 1 |
| Fan, P | 1 |
| Zhang, Y | 1 |
| Zhao, Z | 1 |
| Bauer, N | 1 |
| Mattern, J | 1 |
| Gao, C | 1 |
| Schemmer, P | 1 |
| Jazwa, A | 1 |
| Rojo, AI | 1 |
| Innamorato, NG | 1 |
| Hesse, M | 1 |
| Fernández-Ruiz, J | 1 |
| Cuadrado, A | 1 |
| Ho, JN | 1 |
| Kang, ER | 1 |
| Yoon, HG | 1 |
| Jeon, H | 1 |
| Jun, W | 1 |
| Watson, RR | 1 |
| Lee, J | 1 |
| Conaway, CC | 1 |
| Wang, CX | 1 |
| Pittman, B | 1 |
| Yang, YM | 1 |
| Schwartz, JE | 1 |
| Tian, D | 1 |
| McIntee, EJ | 1 |
| Hecht, SS | 1 |
| Chung, FL | 1 |
1 review available for sulforaphane and Disease Exacerbation
| Article | Year |
|---|---|
Sulforaphane and prostate cancer interception.
Topics: Animals; Anticarcinogenic Agents; Brassica; Diet; Disease Models, Animal; Disease Progression; Human | 2014 |
9 other studies available for sulforaphane and Disease Exacerbation
| Article | Year |
|---|---|
miR-29a-3p-dependent COL3A1 and COL5A1 expression reduction assists sulforaphane to inhibit gastric cancer progression.
Topics: Animals; Anticarcinogenic Agents; Cell Line, Tumor; Collagen Type III; Collagen Type V; Disease Prog | 2021 |
Alleviating the progression of acute myeloid leukemia (AML) by sulforaphane through controlling miR-155 levels.
Topics: Adolescent; Adult; Aged; Apoptosis; Biomarkers, Tumor; Cell Differentiation; Cell Line, Tumor; Child | 2018 |
MicroRNA-365a-3p inhibits c-Rel-mediated NF-κB signaling and the progression of pancreatic cancer.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Mo | 2019 |
The Anti-Inflammatory Effect of Sulforaphane in Mice with Experimental Autoimmune Encephalomyelitis.
Topics: Animals; Anti-Inflammatory Agents; Behavior, Animal; Cervix Uteri; Disease Progression; Encephalomye | 2019 |
A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemot | 2013 |
Continuous exposure of pancreatic cancer cells to dietary bioactive agents does not induce drug resistance unlike chemotherapy.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Carcinogenesis; Cell Line, Tumor; Cell Survival; Clone Cel | 2016 |
Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anticarcinogenic Agents; Antioxidants; Basal | 2011 |
Inhibition of premature death by isothiocyanates through immune restoration in LP-BM5 leukemia retrovirus-infected C57BL/6 mice.
Topics: Animals; Cytokines; Disease Progression; Female; Isothiocyanates; Lipid Peroxidation; Longevity; Mic | 2011 |
Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice.
Topics: Acetylcysteine; Adenocarcinoma; Adenoma; Animals; Anticarcinogenic Agents; Benzo(a)pyrene; Body Weig | 2005 |